Cloning and characterization of slc26a7 and slc26a9 anion exchangers
CA 2477566 A1 · Owner: Romero, Michael F. · Inventors: Mount, David B. Jr.; Romero, Michael F.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Isolated nucleic acids encoding SLC26A7 and SLC26A9 anion transporter polypeptides, recombinantly expressed SLC26A7 and SLC26A9 anion transporter polypeptides, heterologous expression systems for recombinant expression of SLC26A7 and SLC26A9 anion transporter polypeptides assay methods employing , the same, and methods for modulation of anion transport activity.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 28, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 28, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 28, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.